The ex vivo neurotoxic, myotoxic and cardiotoxic activity of cucurbituril-based macrocyclic drug delivery vehicles.
about
Acyclic cucurbit[n]uril-type molecular containers: influence of glycoluril oligomer length on their function as solubilizing agents.Template-controlled synthesis of chiral cyclohexylhemicucurbit[8]uril.Supramolecular Inhibition of Neurodegeneration by a Synthetic ReceptorIn Vitro selectivity of an acyclic cucurbit[n]uril molecular container towards neuromuscular blocking agents relative to commonly used drugs.Probing the pharmacokinetics of cucurbit[7, 8 and 10]uril: and a dinuclear ruthenium antimicrobial complex encapsulated in cucurbit[10]uril.Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients.Encapsulation of Mitoxantrone within Cucurbit[8]uril Decreases Toxicity and Enhances Survival in a Mouse Model of Cancer.Photochemical behavior of biosupramolecular assemblies of photosensitizers, cucurbit[n]urils and albumins.Drug Delivery by Controlling a Supramolecular Host-Guest Assembly with a Reversible Photoswitch.Encapsulation of AGE-Breaker Alagebrium by Cucurbit[7]uril Improved the Stability of Both Its Carbonyl α-Hydrogen and Thiazolium C2-Hydrogen.Molecular Encapsulation of Histamine H₂-Receptor Antagonists by Cucurbit[7]Uril: An Experimental and Computational Study.A systematic evaluation of the biocompatibility of cucurbit[7]uril in mice.Applications of Cucurbit[n ]urils (n =7 or 8) in Pharmaceutical Sciences and Complexation of BiomoleculesInfluence of supramolecular encapsulation of camptothecin by cucurbit[7]uril: reduced toxicity and preserved anti-cancer activityEnhanced in vitro and in vivo uptake of a hydrophobic model drug coumarin-6 in the presence of cucurbit[7]uril
P2860
Q35196330-C9EB6DB0-C904-4E36-9F50-8D44C456979FQ35659322-0AE91904-654F-4142-AFA7-33193FCCD244Q36367293-5E907BAC-6410-4A6A-8EDF-FA5ED96EA8C2Q36483980-4A589CBC-B7C4-4F1C-83AC-84E1489D0DA2Q38690784-B7568D6E-6EC4-4DA7-BCDD-3134079C1C52Q38704930-2FCBD8A6-27F9-43DC-86A8-C67A18165DE4Q39425832-96B85076-A628-46F7-9264-4C22267FB010Q47839279-3FC3E75B-E7A5-44F2-AAE0-3DF8E6E067BDQ48088568-5835B50F-7FE9-4D6E-A9E2-F4A61F9E03F2Q48106786-0682EE1B-1E43-4017-B9A7-83DC6327AD39Q48365468-7EB437C0-2259-4969-85BD-D6D21B9C8813Q51569160-E285899C-0454-4987-969E-AEE17FF15CFAQ55235308-00890528-7085-4726-B9D1-D3C503B5B417Q57617975-E0116BFD-7AB4-4C69-AA46-4E42319ACFBFQ57618017-EA368CB3-9DB6-4123-9C2A-596091242C11Q57618030-7A2294AD-D4DF-4DBB-B3BF-D4105F7549D8
P2860
The ex vivo neurotoxic, myotoxic and cardiotoxic activity of cucurbituril-based macrocyclic drug delivery vehicles.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@ast
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@en
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@nl
type
label
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@ast
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@en
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@nl
prefLabel
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@ast
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@en
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@nl
P2860
P50
P356
P1433
P1476
The ex vivo neurotoxic, myotox ...... cyclic drug delivery vehicles.
@en
P2093
Rabbab Oun
P2860
P304
P356
10.1039/C4TX00082J
P577
2014-11-01T00:00:00Z